Cranioectodermal dysplasia
MONDO:0009032Cranioectodermal dysplasia (CED) is a rare developmental disorder characterized by congenital skeletal and ectodermal defects associated with dysmorphic features, nephronophthisis, hepatic fibrosis and ocular anomalies (mainly retinitis pigmentosa).
Also known as: CED, Sensenbrenner syndrome, cranioectodermal dysplasia
2 clinical trials for this condition and its sub-types, 0 tagged with Cranioectodermal dysplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cranioectodermal dysplasia
-
Cranioectodermal dysplasia 1 0 trials
-
Cranioectodermal dysplasia 2 0 trials
-
Cranioectodermal dysplasia 3 0 trials
-
Cranioectodermal dysplasia 4 0 trials
-
Cranioectodermal dysplasia 5 0 trials
-
Cranioectodermal dysplasia 6 0 trials
-
Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders
Disease control Recruiting nowThis early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected ar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a diabetes drug protect kidneys in children with genetic disease?
Disease control Recruiting nowThis study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…
Phase 3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC